Varlıklar Değişiklik Tarih
AbbVie USD 136.46B 2.5B 2026-03
Abbott USD 110.43B 23.72B 2026-03
Amgen USD 92.5B 1.92B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Baxter International USD 19.85B 209M 2026-03
Bayer EUR 107.94B 3.4B 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Biogen USD 29.48B 43.6M 2026-03
Boston Scientific USD 44.35B 678M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
CONMED USD 2.31B 10.81M 2026-03
Cooper Companies USD 12.48B 58.1M 2026-03
Dexcom USD 6.63B 293.4M 2026-03
Edwards Lifesciences USD 13.32B 376M 2026-03
Eli Lilly USD 116.58B 4.1B 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Globus Medical USD 5.44B 136.79M 2026-03
Insulet USD 2.99B 203.2M 2026-03
Integra LifeSciences USD 3.58B 24.28M 2026-03
Intuitive Surgical USD 20.11B 347.7M 2026-03
J&J USD 200.89B 1.68B 2026-03
Medtronic USD 91.48B 139M 2025-12
Merck USD 128.68B 8.18B 2026-03
Merit Medical Systems USD 2.72B 33.36M 2026-03
Novartis USD 118.53B 7.58B 2026-03
Pfizer USD 207.62B 542M 2026-03
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 128.02B 1.22B 2026-03
Stryker USD 46.29B 1.55B 2026-03
Tandem Diabetes Care USD 1.15B 272.28M 2026-03
Teva Pharmaceutical Industries USD 40.04B 708M 2026-03
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03
Zimmer Biomet Holdings USD 22.72B 370.1M 2026-03
Zoetis USD 15.15B 313M 2026-03